$0.405500
-0.01-3.45%
At Close: -
$0.406000
0.00050.12%
After Hours: 7:31 PM EDT
15 minutes delayed
Bionano Genomics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Bionano Genomics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $-0.24 | $-0.42 | 42.9 % |
Mar 2024 | 2024-05-08 | $-0.60 | $-0.64 | 6.25 % |
Dec 2023 | 2024-03-05 | $-0.96 | $-0.87 | -10.3 % |
Sep 2023 | 2023-11-08 | $-1.01 | $-0.94 | -7.45 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $7.77M | $8.00M | -2.86 % |
Mar 2024 | 2024-05-08 | $8.77M | $8.49M | 3.29 % |
Dec 2023 | 2024-03-05 | $10.72M | $10.58M | 1.33 % |
Sep 2023 | 2023-11-08 | $9.32M | $8.98M | 3.76 % |
Bionano Genomics (BNGO) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 7, 2024 for Q2.
The Actual EPS was $-0.24, which beat the estimate of $-0.42.
The Actual Revenue was $7.8M, which missed the estimate of $8M.
Browse earnings estimates, EPS, and revenue on all stocks.